Radiological imaging in multiple myeloma: review of the state-of-the-art

Dimopoulos M, Terpos E, Comenzo RL et al (2009) International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia Palumbo A, Bringhen S, Ludwig H et al (2011) Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood Lorsbach RB (2010) Update on the diagnosis and classification of the plasma cell neoplasms. Surg Pathol Clin Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood Castillo JJ, Treon SP (2019) What is new in the treatment of Waldenstrom macroglobulinemia? Leukemia. 33:2555–2562. https://doi.org/10.1038/s41375-019-0592-8 Grammatico S, Scalzulli E, Petrucci MT (2017) Mediterranean journal of hematology and infectious diseases solitary plasmacytoma. Mediterr J Hematol Infect Dis. https://doi.org/10.4084/MJHID.2017.052 Bahlis NJ, Lazarus HM (2006) Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted? Bone Marrow Transplant Rane S, Rana S, Mudrabettu C et al (2012) Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment. Clin Kidney J Moreau P, San Miguel J, Sonneveld P et al (2017) Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. https://doi.org/10.1093/annonc/mdx096 Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S (2018) Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group. Blood Cancer J 8:1–9. https://doi.org/10.1038/s41408-018-0124-1 Chantry A, Kazmi M, Barrington S et al (2017) Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol. https://doi.org/10.1111/bjh.14827 Weber FP (2005) Multiple myeloma (myelomatosis) with Bence-Jones proteid in the urine (myelopathic albumosuria of Bradshaw, Kahler’s disease.). J Pathol Bacteriol. https://doi.org/10.1002/path.1700090205 Baur-Melnyk A, Buhmann S, Becker C et al (2008) Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. Am J Roentgenol. https://doi.org/10.2214/AJR.07.2635 Baur-Melnyk A, Reiser M (2004) Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography . Staging des Mult myeloms mit der MRT Vergleich zur MSCT und zur konventionellen röntgendiagnostik Terpos E, Moulopoulos LA, Dimopoulos MA (2011) Advances in imaging and the management of myeloma bone disease. J Clin Oncol Ågren B, Loqvist B, Bjorkstrand B et al (2009) Radiography and bone scintigraphy in bone marrow transplant multiple myeloma patients. Acta Radiol. https://doi.org/10.3109/02841859709171259 Wahlin A, Holm J, Osterman G, Norberg B (1982) Evaluation of serial bone X-ray examination in multiple myeloma. Acta Med Scand. https://doi.org/10.1111/j.0954-6820.1982.tb03234.x Dinter DJ, Neff WK, Klaus J et al (2009) Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol. https://doi.org/10.1007/s00277-008-0621-6 Schreiman JS, McLeod RA, Kyle RA, Beabout JW (2014) Multiple myeloma: evaluation by CT. Radiology. https://doi.org/10.1148/radiology.154.2.3966137 Mahnken AH, Wildberger JE, Gehbauer G et al (2002) Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. Am J Roentgenol. https://doi.org/10.2214/ajr.178.6.1781429 Horger M, Claussen CD, Bross-Bach U et al (2005) Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2004.04.015 Kröpil P, Fenk R, Fritz LB et al (2008) Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol. https://doi.org/10.1007/s00330-007-0738-3 Gleeson TG, Byrne B, Kenny P et al (2010) Image quality in low-dose multidetector computed tomography: a pilot study to assess feasibility and dose optimization in whole-body bone imaging. Can Assoc Radiol J. https://doi.org/10.1016/j.carj.2010.01.003 Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol Horger M, Pereira P, Claussen CD et al (2008) Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: Correlation with haematological parameters. Br J Radiol. https://doi.org/10.1259/bjr/21850180 Hillengass J, Moulopoulos LA, Delorme S, Koutoulidis V, Mosebach J, Hielscher T, Drake M, Rajkumar SV, Oestergaard B, Abildgaard N, Hinge M, Plesner T, Suehara Y, Matsue K, Withofs N, Caers J, Waage A, Goldschmidt H, Dimopoulos MA, Lentzsch S, Durie B, Terpos E (2017) Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood Cancer J 7. https://doi.org/10.1038/bcj.2017.78 Husband JE, Schwartz LH, Spencer J et al (2004) Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society. In: British Journal of Cancer Zambello R, Crimì F, Lico A, Barilà G, Branca A, Guolo A, Varin C, Vezzaro R, Checuz L, Scapin V, Berno T, Pizzi M, Ponzoni A, Biasi E, Vio S, Semenzato G, Zucchetta P, Lacognata C (2019) Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI. Ann Hematol 98:679–689. https://doi.org/10.1007/s00277-018-3555-7 Ippolito D, Besostri V, Bonaffini PA et al (2013) Diagnostic value of whole-body low-dose computed tomography(WBLDCT) in bone lesions detection in patients with multiplemyeloma (MM). Eur J Radiol. https://doi.org/10.1016/j.ejrad.2013.08.036 Rajkumar SV (2015) Evolving diagnostic criteria for multiple myeloma. Hematology Heß T, Egerer G, Kasper B et al (2006) Atypical manifestations of multiple myeloma: radiological appearance. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2005.11.015 Gleeson TG, Moriarty J, Shortt CP et al (2009) Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skelet Radiol. https://doi.org/10.1007/s00256-008-0607-4 Johnson TRC (2012) Dual-energy CT: general principles. AJR Am J Roentgenol Johnson TRC, Krauß B, Sedlmair M et al (2007) Material differentiation by dual energy CT: Initial experience. Eur Radiol. https://doi.org/10.1007/s00330-006-0517-6 Rutherford RA, Pullan BR, Isherwood I (1976) X-ray energies for effective atomic number determination. Neuroradiology. 11:23–28. https://doi.org/10.1007/BF00327254 Alvarez RE, MacOvski A (1976) Energy-selective reconstructions in X-ray computerised tomography. Phys Med Biol. https://doi.org/10.1088/0031-9155/21/5/002 Kosmala A, Weng AM, Heidemeier A et al (2017) Multiple myeloma and dual-energy CT: diagnostic accuracy of virtual noncalcium technique for detection of bone marrow infiltration of the spine and pelvis. Radiology. https://doi.org/10.1148/radiol.2017170281 Thomas C, Schabel C, Krauss B et al (2015) Dual-energy CT: virtual calcium subtraction for assessment of bone marrow involvement of the spine in multiple myeloma. In: American Journal of Roentgenology Kosmala A, Weng AM, Krauss B, Knop S, Bley TA, Petritsch B (2018) Dual-energy CT of the bone marrow in multiple myeloma: diagnostic accuracy for quantitative differentiation of infiltration patterns. Eur Radiol 28:5083–5090. https://doi.org/10.1007/s00330-018-5537-5 Yu Z, Leng S, Jorgensen SM et al (2016) Evaluation of conventional imaging performance in a research whole-body CT system with a photon-counting detector array. Phys Med Biol. https://doi.org/10.1088/0031-9155/61/4/1572 Goo HW, Goo JM (2017) Dual-energy CT: new horizon in medical imaging. Korean J Radiol Zamagni E, Nanni C, Patriarca F et al (2007) A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. https://doi.org/10.3324/haematol.10554 Hillengass J, Landgren O (2013) Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging early myeloma. Leuk Lymphoma Walker R, Barlogie B, Haessler J et al (2007) Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol. https://doi.org/10.1200/JCO.2006.08.5803 Regelink JC, Minnema MC, Terpos E et al (2013) Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol. https://doi.org/10.1111/bjh.12346 Rasche L, Angtuaco E, McDonald JE et al (2017) Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma. Blood. https://doi.org/10.1182/blood-2017-03-774422 Lindsey JD, Becker PS, Conrad EU (2016) My Myeloma : eloma : diagnosis and management. NICE Guidel Hillengass J, Fechtner K, Weber MA et al (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol. https://doi.org/10.1200/JCO.2009.25.5356 Rajkumar SV (2016) Myeloma today: disease definitions and treatment advances. Am J Hematol. https://doi.org/10.1002/ajh.24236 Rahmouni A, Divine M, Mathieu D et al (1993) Detection of multiple myeloma involving the spine: efficacy of fat- suppression and contrast-enhanced MR imaging. Am J Roentgenol. https://doi.org/10.2214/ajr.160.5.8470574 Ma J (2008) A single-point dixon technique for fat-suppressed fast 3D gradient-echo imaging with a flexible echo time. J Magn Reson Imaging. https://doi.org/10.1002/jmri.21281 Shah LM, Hanrahan CJ (2011) MRI of spinal bone marrow: part 1, techniques and normal age-related appearances. Am J Roentgenol Dixon WT (1984) Simple proton spectroscopic imaging. Radiology. https://doi.org/10.1148/radiology.153.1.6089263 Yoo HJ, Hong SH, Kim DH et al (2017) Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes. J Magn Reson Imaging. https://doi.org/10.1002/jmri.25496 Kirchgesner T, Perlepe V, Michoux N et al (2017) Fat suppression at 2D MR imaging of the hands: Dixon method versus CHESS technique and STIR sequence. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2017.01.011 Guerini H, Omoumi P, Guichoux F et al (2015) Fat suppression with Dixon techniques in musculoskeletal magnetic resonance imaging: a pictorial review. Semin Musculoskelet Radiol van Vucht N, Santiago R, Lottmann B et al (2019) The Dixon technique for MRI of the bone marrow. Skelet Radiol Bray TJP, Singh S, Latifoltojar A et al (2017) Diagnostic utility of whole body Dixon MRI in multiple myeloma: a multi-reader study. PLoS One. https://doi.org/10.1371/journal.pone.0180562 Lee S, Choi DS, Shin HS et al (2018) FSE T2-weighted two-point dixon technique for fat suppression in the lumbar spine: comparison with SPAIR technique. Diagn Interv Radiol. https://doi.org/10.5152/dir.2018.17320 Huijgen WHF, van Rijswijk CSP, Bloem JL (2019) Is fat suppression in T1 and T2 FSE with mDixon superior to the frequency selection-based SPAIR technique in musculoskeletal tumor imaging? Skelet Radiol 48:1905–1914. https://doi.org/10.1007/s00256-019-03227-8 Danner A, Brumpt E, Alilet M et al (2019) Improved contrast for myeloma focal lesions with T2-weighted Dixon images compared to T1-weighted images. Diagn Interv Imaging. https://doi.org/10.1016/j.diii.2019.05.001 Maeder Y, Dunet V, Richard R et al (2018) Bone marrow metastases: T2-weighted Dixon spin-echo fat images can replace T1-weighted spin-echo images. Radiology. https://doi.org/10.1148/radiol.2017170325 Messiou C, Hillengass J, Delorme S et al (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. https://doi.org/10.1148/radiol.2019181949 Silva JR, Hayashi D, Yonenaga T et al (2013) MRI of bone marrow abnormalities in hematological malignancies. Diagn Interv Radiol. https://doi.org/10.5152/dir.2013.067 Dutoit JC, Vanderkerken MA, Anthonissen J, Dochy F, Verstraete KL (2014) The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma. Eur Radiol 24:2754–2765. https://doi.org/10.1007/s00330-014-3324-5 Alyas F, Saifuddin A, Connell D (2007) MR imaging evaluation of the bone marrow and marrow infiltrative disorders of the lumbar spine. Magn Reson Imaging Clin N Am Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2005.01.017 Stäbler A, Baur A, Bartl R et al (1996) Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. Am J Roentgenol. https://doi.org/10.2214/ajr.167.4.8819407 Lecouvet FE, Vande Berg BC, Michaux L et al (2014) Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology. https://doi.org/10.1148/radiology.209.3.9844655 Caers J, Withofs N, Hillengass J et al (2014) The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma. Haematologica Baliyan V, Das CJ, Sharma R, Gupta AK (2016) Diffusion weighted imaging: technique and applications. World J Radiol. https://doi.org/10.4329/wjr.v8.i9.785 Kwee TC, Takahara T, Ochiai R et al (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol. https://doi.org/10.1007/s00330-008-0968-z Messiou C, Giles S, Collins DJ et al (2012) Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol. https://doi.org/10.1259/bjr/52759767 Messiou C, Kaiser M (2015) Whole body diffusion weighted MRI - a new view of myeloma. Br J Haematol Huang S-Y, Chen B-B, Lu H-Y et al (2012) Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma. Am J Hematol. https://doi.org/10.1002/ajh.23256 Messiou C, Collins DJ, Morgan VA, Desouza NM (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol. https://doi.org/10.1007/s00330-011-2116-4 Padhani AR, Van Ree K, Collins DJ et al (2013) Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. Am J Roentgenol. https://doi.org/10.2214/AJR.11.8185 Perez-Lopez R, Rodrigues DN, Figueiredo I et al (2018) Multiparametric magnetic resonance imaging of prostate cancer bone disease correlation with bone biopsy histological and molecular features. Investig Radiol. https://doi.org/10.1097/RLI.0000000000000415 Winfield JM, Poillucci G, Blackledge MD, Collins DJ, Shah V, Tunariu N, Kaiser MF, Messiou C (2018) Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI. Eur Radiol 28:1687–1691. https://doi.org/10.1007/s00330-017-5079-2 Dutoit JC, Verstraete KL (2016) MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings. Insights Imaging Lacognata C, Crimì F, Guolo A et al (2017) Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol. https://doi.org/10.1016/j.crad.2017.05.004 Pearce T, Philip S, Brown J et al (2012) Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI. Br J Radiol. https://doi.org/10.1259/bjr/30649204 Terpos E, Kleber M, Engelhardt M et al (2015) European myeloma network guidelines for the management of multiple myeloma-related complications. Haematologica. https://doi.org/10.3324/haematol.2014.117176 Wu LM, Gu HY, Zheng J et al (2011) Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis. J Magn Reson Imaging. https://doi.org/10.1002/jmri.22608 Lecouvet FE, El Mouedden J, Collette L et al (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol. https://doi.org/10.1016/j.eururo.2012.02.020 Hillengass J, Stoll J, Zechmann CM, Kunz C, Wagner B, Heiss C, Sumkauskaite M, Moehler TM, Schlemmer HP, Goldschmidt H, Delorme S (2015) The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken. Eur Radiol 25:745–750. https://doi.org/10.1007/s00330-014-3458-5 Verstraete KL, Van der Woude H-J, Hogendoorn PCW et al (2007) Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging. https://doi.org/10.1002/jmri.1880060210 Dutoit JC, Vanderkerken MA, Verstraete KL (2013) Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2013.04.012 Lavini C, de Jonge MC, van de Sande MGH et al (2007) Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging. https://doi.org/10.1016/j.mri.2006.10.021 García-Figueiras R, Padhani AR, Beer AJ et al (2015) Imaging of tumor angiogenesis for radiologists-part 1: biological and technical basis. Curr Probl Diagn Radiol Dimopoulos MA, Hillengass J, Usmani S et al (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol. https://doi.org/10.1200/JCO.2014.57.9961 Boellaard R, Delgado-Bolton R, Oyen WJG, et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging Valls L, Badve C, Avril S et al (2016) FDG-PET imaging in hematological malignancies. Blood Rev Weiler-Sagie M, Bushelev O, Epelbaum R et al (2010) 18F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. https://doi.org/10.2967/jnumed.109.067892 El Arfani C, De Veirman K, Maes K et al (2018) Metabolic features of multiple myeloma. Int J Mol Sci Zhang XD, Deslandes E, Villedieu M et al (2006) Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro. Anticancer Res Zhang D, Li J, Wang F et al (2014) 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett Bolzoni M, Chiu M, Accardi F et al (2016) Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target. Blood. https://doi.org/10.1182/blood-2016-01-690743 Moreau P, Attal M, Caillot D et al (2017) Prospective evaluation of magnetic resonance imaging and [18F]fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM/DFCI 2009 trial. In: Journal of Clinical Oncology Terpos E, Dimopoulos MA, Sezer O (2007) The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma. Leukemia Zamagni E, Patriarca F, Nanni C et al (2011) Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood. https://doi.org/10.1182/blood-2011-06-361386 Bannas P, Hentschel HB, Bley TA et al (2012) Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation. Eur Radiol. https://doi.org/10.1007/s00330-012-2445-y Cavo M, Terpos E, Nanni C et al (2017) Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol Lückerath K, Lapa C, Albert C et al (2015) 11C-methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma. Oncotarget. https://doi.org/10.18632/oncotarget.3053 Ho CL, Chen S, Leung YL et al (2014) 11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT. J Nucl Med. https://doi.org/10.2967/jnumed.113.131169 Brigle K, Pierre A, Finley-Oliver E et al (2017) Myelosuppression, bone disease, and acute renal failure: evidence-based recommendations for oncologic emergencies. Clin J Oncol Nurs Terpos E, Christoulas D, Gavriatopoulou M (2018) Biology and treatment of myeloma related bone disease. Metabolism. https://doi.org/10.1016/j.metabol.2017.11.012 Avva R, Vanhemert RL, Barlogie B et al (2001) CT-guided biopsy of focal lesions in patients with multiple myeloma may reveal new and more aggressive cytogenetic abnormalities. Am J Neuroradiol Mink J (1986) Percutaneous bone biopsy in the patient with known or suspected osseous metastases. Radiology. https://doi.org/10.1148/radiology.161.1.3763865 Thumallapally N, Meshref A, Mousa M, Terjanian T (2017) Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer. https://doi.org/10.1186/s12885-016-3015-5 Dimopoulos M, Kyle R, Fermand JP et al (2011) Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. In: Blood Engelhardt M, Udi J, Kleber M et al (2010) European myeloma network: the 3rd Trialist forum consensus statement from the European experts meeting on multiple myeloma. Leuk Lymphoma Melton LJ, Crowson CS, O’Fallon WM (1999) Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int. https://doi.org/10.1007/s001980050113 Melton LJ, Kyle RA, Achenbach SJ et al (2005) Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res. https://doi.org/10.1359/JBMR.041131 Cotten A, Dewatre F, Cortet B et al (1996) Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology. https://doi.org/10.1148/radiology.200.2.8685351 Ha KY, Kim YH, Kim HW (2013) Multiple myeloma and epidural spinal cord compression: case presentation and a spine surgeon’s perspective. J Korean Neurosurg Soc. https://doi.org/10.3340/jkns.2013.54.2.151 Wallington M, Mendis S, Premawardhana U et al (1997) Local control and survival in spinal cord compression from lymphoma and myeloma. Radiother Oncol. https://doi.org/10.1016/S0167-8140(96)01858-0 Kyriakou C, Molloy S, Vrionis F, Alberico R, Bastian L, Zonder JA, Giralt S, Raje N, Kyle RA, Roodman DGD, Dimopoulos MA, Rajkumar SV, Durie BBG, Terpos E (2019) The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG). Blood Cancer J 9:1–10. https://doi.org/10.1038/s41408-019-0187-7 Soutar R, Lucraft H, Jackson G et al (2004) Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol Baerlocher MO, Saad WE, Dariushnia S et al (2014) Quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol. https://doi.org/10.1016/j.jvir.2013.09.004 Jensen ME, McGraw JK, Cardella JF (2011) Position statement on percutaneous vertebral augmentation: a consensus statement developed by the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Association of Neurological Surgeons/Congres. J Neurointerv Surg Calmels V, Vallée JN, Rose M, Chiras J (2007) Osteoblastic and mixed spinal metastases: evaluation of the analgesic efficacy of percutaneous vertebroplasty. Am J Neuroradiol. https://doi.org/10.1016/s1073-5437(08)70967-7 Zheng L, Chen Z, Sun M et al (2014) A preliminary study of the safety and efficacy of radiofrequency ablation with percutaneous kyphoplasty for thoracolumbar vertebral metastatic tumor treatment. Med Sci Monit. https://doi.org/10.12659/MSM.889742 Wallace AN, Greenwood TJ, Jennings JW (2015) Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastases. J Neuro-Oncol. https://doi.org/10.1007/s11060-015-1813-2 Erdem E, Akdol S, Amole A et al (2013) Radiofrequency-targeted vertebral augmentation for the treatment of vertebral compression fractures as a result of multiple myeloma. Spine (Phila Pa 1976). https://doi.org/10.1097/BRS.0b013e3182959695 Barbero S, Casorzo I, Durando M, Mattone G, Tappero C, Venturi C, Gandini G (2008) Percutaneous vertebroplasty: the follow-up. Radiol Med 113:101–113. https://doi.org/10.1007/s11547-008-0234-0 Gozzetti A, Cerase A, Defina M, Bocchia M (2012) Plasmacytoma of the skull. Eur J Haematol Cerase A, Tarantino A, Gozzetti A et al (2008) Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology Gozzetti A, Cerase A, Tarantino A et al (2007) Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib. Clin Lymphoma Myeloma. https://doi.org/10.3816/CLM.2007.n.017 Jurczyszyn A, Grzasko N, Gozzetti A et al (2016) Central nervous system involvement by multiple myeloma: a multi-institutional retrospective study of 172 patients in daily clinical practice. Am J Hematol. https://doi.org/10.1002/ajh.24351 Rosenberg S, Shapur N, Gofrit O, Or R (2010) Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site? J Clin Oncol. https://doi.org/10.1200/JCO.2009.27.6519 Anghel G, Petti N, Remotti D et al (2002) Testicular plasmacytoma: report of a case and review of the literature. Am J Hematol. https://doi.org/10.1002/ajh.10174 Gozzetti A, Cerase A, Lotti F et al (2012) Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients. Cancer. https://doi.org/10.1002/cncr.26447 Ooi GC, Chim JCS, Au WY, Khong PL (2006) Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomas. Am J Roentgenol Sanchorawala V (2006) Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol Lee SP, Park JB, Kim HK et al (2019) Contemporary imaging diagnosis of cardiac amyloidosis. J Cardiovasc Imaging Palladini G, Hegenbart U, Milani P et al (2014) A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. https://doi.org/10.1182/blood-2014-04-570010 Kawashima A, Alleman WG, Takahashi N et al (2011) Imaging evaluation of amyloidosis of the urinary tract and retroperitoneum. Radiographics. https://doi.org/10.1148/rg.316115519 Czeyda-Pommersheim F, Hwang M, Chen SS et al (2015) Amyloidosis: modern cross-sectional imaging. Radiographics. https://doi.org/10.1148/rg.2015140179 Dispenzieri A (2017) POEMS syndrome: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. https://doi.org/10.1002/ajh.24802 Paiva B, García-Sanz R, San Miguel JF (2016) Multiple myeloma minimal residual disease. In: Cancer Treatment and Research Kumar S, Paiva B, Anderson KC et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol Zamagni E, Cavo M (2012) The role of imaging techniques in the management of multiple myeloma. Br J Haematol